Menu

Recent Advances in Immunotherapy: Directing Cells to Address Disease

The Scientist is bringing together a panel of experts to review the past, present, and future of immunotherapy, and share the details of their research into new treatments. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Mar 29, 2017
The Scientist Creative Services Team

Recent Advances in Immunotherapy: Directing Cells to Address Disease from thescientistllc on Vimeo.

To target diseases such as cancer and HIV, scientists are now successfully programming the immune system to seek out and destroy the agents of disease, even when those agents are the body’s own cells. Immunotherapy has demonstrated remarkable efficacy in treatment of previously undruggable diseases, leading to calls for standardization and additional research. The Scientist is bringing together a panel of experts to review the current knowledge base, share their recent work, and discuss the future of immunotherapy. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • Progress in immunotherapies, from cancer to HIV
  • Immunotherapy research and development

View the Video Now

Meet the Speakers:

Leena Gandhi, MD, PhD
Director, Thoracic Medical Oncology,
 NYU Langone Medical Center
Associate Professor, Department of Medicine,
 NYU Perlmutter Cancer Center

 

 


 

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Libraries of pooled lentiviral constructs that express two different sgRNA to all 19,000 human protein-coding genes improve overall gene activation or repression and generate more robust screening results
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
In this webinar, learn about antibody-drug conjugates (ADCs) and their function, how to analyze and characterize ADCs, and developing ADC processes and formulations.
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3.